Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 YearsYves Deugnier, Pierre Brissot, John B. Porter et al.|Gastroenterology|2011Cited by 89
Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron OverloadYves Deugnier, Pierre Brissot, Bruno Turlin et al.|Blood|2010Cited by 3